IBB Holdings Information

IBB is an equity ETF with a total of 263 individual holdings. The top holdings are Gilead Sciences stock at 9.12%, Vertex Pharmaceuticals at 8.77%, Amgen at 8.00%, Regeneron Pharmaceuticals at 6.48%, and Alnylam Pharmaceuticals at 3.79%.

Total Holdings

263

Top 10 Percentage

48.98%

Asset Class

Equity

ETF Category

Health

Assets

8.63B

PE Ratio

24.11

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	9.12%	5,469,239
2	VRTX	Vertex Pharmaceuticals Incorporated	8.77%	1,587,260
3	AMGN	Amgen Inc.	8.00%	1,992,260
4	REGN	Regeneron Pharmaceuticals, Inc.	6.48%	743,867
5	ALNY	Alnylam Pharmaceuticals, Inc.	3.79%	953,909
6	ARGX	argenx SE	2.94%	297,537
7	INSM	Insmed Incorporated	2.85%	1,546,031
8	NTRA	Natera, Inc.	2.62%	965,506
9	BIIB	Biogen Inc.	2.28%	1,076,589
10	ONC	BeOne Medicines AG	2.13%	531,533
11	ILMN	Illumina, Inc.	1.86%	1,091,775
12	UTHR	United Therapeutics Corporation	1.68%	305,344
13	INCY	Incyte Corporation	1.68%	1,427,539
14	GMAB	Genmab A/S	1.39%	3,614,590
15	RVMD	Revolution Medicines, Inc.	1.38%	1,215,185
16	MRNA	Moderna, Inc.	1.32%	2,547,893
17	NBIX	Neurocrine Biosciences, Inc.	1.14%	713,636
18	MEDP	Medpace Holdings, Inc.	1.14%	166,115
19	IONS	Ionis Pharmaceuticals, Inc.	1.13%	1,167,726
20	BBIO	BridgeBio Pharma, Inc.	1.10%	1,209,576
21	EXEL	Exelixis, Inc.	0.93%	1,908,810
22	BMRN	BioMarin Pharmaceutical Inc.	0.92%	1,391,585
23	ASND	Ascendis Pharma A/S	0.91%	340,614
24	CRL	Charles River Laboratories International, Inc.	0.88%	357,603
25	MDGL	Madrigal Pharmaceuticals, Inc.	0.87%	151,619

Showing 25 of 263 holdings

Subscribe to see the full list

Activate Now

As of Jan 30, 2026